REQUEST A DEMO
Total
USD $0.00
Search more companies

Refarmed Chemicals (India) Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Refarmed Chemicals (India) Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Refarmed Chemicals (india) Private Limited is an unlisted company, incorporated on 13/07/2005. It has its registered office in the State of Delhi, India. Company's corporate identification number (CIN) is U24230DL2005PTC169317 and registration number is 169317. The company is a trade company, it is engaged in wholesale trading.

Legal Address
S-78, Greater Kailash I
South Delhi; Delhi; Postal Code: 110048

Contact Details: Purchase the Refarmed Chemicals (India) Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Refarmed Chemicals (India) Private Limited report to view the information.
Registered Capital:
Purchase the Refarmed Chemicals (India) Private Limited report to view the information.
Incorporation Date:
July 13, 2005
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
70%
Purchase this report to view the information.
20%
Subsidiaries
Pleasantville Investments Private Limited
27.03%
Company Performance
Financial values in the chart are available after Refarmed Chemicals (India) Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-2.31%
Total operating revenue
-1.58%
Operating profit (EBIT)
66.15%
EBITDA
64.53%
Net Profit (Loss) for the Period
68.21%
Total assets
-32.56%
Total equity
25.06%
Operating Profit Margin (ROS)
3.51%
Net Profit Margin
2.57%
Return on Equity (ROE)
5.14%
Quick Ratio
1.22%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?